304 Cluster analysis of preterm birth and neonatal adverse outcomes in low-risk nulliparous women Antonio Saad for the Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network, Bethesda, MD OBJECTIVE: To use unsupervised learning approaches to detect mechanistic clusters associated with preterm birth (PTB) and adverse neonatal outcome among nulliparous women.
STUDY DESIGN: Secondary analysis of a multicenter prediction study embedded within a randomized trial to prevent preeclampsia in nulliparous women. The trial result was negative so treatment groups were combined for this analysis. Patients had blood drawn during the first trimester and uterine artery Doppler (UAD) performed before 21 weeks of gestation. Outcomes were ascertained by trained research coordinators. The primary outcome for this analysis was PTB < 37 weeks. The secondary outcome was an adverse neonatal outcome composite (ANC) defined as either perinatal death, a 5-minute Apgar score < 4, seizures, intubation in the delivery room, intraventricular hemorrhage, necrotizing enterocolitis, sepsis, or NICU admission > 48 hours. Cellular fibronectin, CRP, endoglin, IGFBP-1, leptin, PlGF, sFLT-1, ADAM12, PAPP-A, and PP13 were determined for selected women, and combined with UAD measures, as well as with clinical characteristics in a principal component analysis followed by a hierarchical clustering analysis to identify potential mechanistic clusters associated with PTB and ANC. RESULTS: 620 women were included in this analysis. Of these, 63 (10.2%) had PTB and 88 (14.3%) had the ANC. Three clusters (subgroups) of patients were identified; patient characteristics among clusters are summarized in the Table. All characteristics were significantly different among clusters except cellular fibronectin, CRP and ADAM12. Additionally, there were significant differences in the frequency of PTB (8.6%, 8.4%, 16.1%; ), but not of ANC, among these clusters. CONCLUSION: Using an unsupervised learning approach, we were able to stratify 3 clusters of nulliparous women with differing PTB characteristics and risks. Further studies are needed to elucidate the relevant biological pathways, and to improve stratification and phenotyping of patients at risk for PTB.
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